Life Sciences

Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.

 

Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.

 

We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.

Our Latest thinking

How CDMOs are leading innovation for pharmaceutical partners

Discover how CDMO M&A trends show CDMOs are becoming emerging technology leaders for pharmaceutical partners.

14 Jul 2022 Dr. Isabelle Heiber

Are digital twins key to more personal, equitable and efficient care?

Digital patient twins tap into the transformative value data beyond the traditional medical to provide health providers and payers actionable insights. Learn more at ey.com/smarthealth.

25 Feb 2022

Why genome editing technologies are creating buzz in medicine

Technologies that allow genomic alteration are gaining in popularity, but they’ll need to overcome key hurdles to become mainstream. Learn more.

05 Oct 2021 Dr. Isabelle Heiber +1

    Life Sciences 4.0

    When the human body is the biggest data platform, who will capture value?



    Contact us
    Like what you’ve seen? Get in touch to learn more.
    You are visiting EY kr (en)
    kr en